Mainz Biomed NV (Mainz Biomed NV) Beginning Cash Position : $9.32 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Beginning Cash Position?

Mainz Biomed NV's Beginning Cash Position for the quarter that ended in Dec. 2023 was $9.32 Mil.

Mainz Biomed NV's quarterly Beginning Cash Position increased from Jun. 2023 ($10.86 Mil) to Sep. 2023 ($10.91 Mil) but then declined from Sep. 2023 ($10.91 Mil) to Dec. 2023 ($9.32 Mil).

Mainz Biomed NV's annual Beginning Cash Position increased from Dec. 2021 ($0.12 Mil) to Dec. 2022 ($8.73 Mil) and increased from Dec. 2022 ($8.73 Mil) to Dec. 2023 ($17.14 Mil).

Mainz Biomed NV Beginning Cash Position Historical Data

The historical data trend for Mainz Biomed NV's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Beginning Cash Position Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

0.23

0.20

0.12

8.73

17.14

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial								22.01	17.14	10.86	10.91	9.32

Mainz Biomed NV Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Mainz Biomed NV Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV (Mainz Biomed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

4TO:Germany

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.